This suggests that although the role of Aβ is similar in both typical and atypical AD, the different topography of tau pathology may culminate into distinct clinical symptoms in line with other studies [14,15,17] However, the interaction between amyloid and tau and their influences on neurodegenerative processes are still unclear. This evidence concerns the gene MAPT and Alzheimer disease.